GPX4 and diffuse large B-cell lymphoma: Similarly, in DLBCL, increased expression of GPX4 gives rise resistance to ROS-induced cell death and is associated with poor outcome in the patients, indicating that malignant cells turn on the antioxidant mechanism to survive [38].